Tag Archives: CEA

Improving the quality of sight in artificial retinas

Researchers at France’s Centre national de la recherche scientifique (CNRS) and elsewhere have taken a step forward to improving sight derived from artificial retinas according to an Aug. 25, 2016 news item on Nanowerk (Note: A link has been removed),

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear. By comparing in rodents the activity of the visual cortex generated artificially by implants against that produced by “natural sight”, scientists from CNRS, CEA [Commissariat à l’énergie atomique et aux énergies alternatives is the French Alternative Energies and Atomic Energy Commission], INSERM [Institut national de la santé et de la recherche médicale is the French National Institute of Health and Medical Research], AP-HM [Assistance Publique – Hôpitaux de Marseille] and Aix-Marseille Université identified two factors that limit the resolution of prostheses.

Based on these findings, they were able to improve the precision of prosthetic activation. These multidisciplinary efforts, published on 23 August 2016 in eLife (“Probing the functional impact of sub-retinal prosthesis”), thus open the way towards further advances in retinal prostheses that will enhance the quality of life of implanted patients.

An Aug. 24, 2015 CNRS press release, which originated the news item, expands on the theme,

A retinal prosthesis comprises three elements: a camera (inserted in the patient’s spectacles), an electronic microcircuit (which transforms data from the camera into an electrical signal) and a matrix of microscopic electrodes (implanted in the eye in contact with the retina). This prosthesis replaces the photoreceptor cells of the retina: like them, it converts visual information into electrical signals which are then transmitted to the brain via the optic nerve. It can treat blindness caused by a degeneration of retinal photoreceptors, on condition that the optical nerve has remained functional1. Equipped with these implants, patients who were totally blind can recover visual perceptions in the form of light spots, or phosphenes.  Unfortunately, at present, the light signals perceived are not clear enough to recognize faces, read or move about independently.

To understand the resolution limits of the image generated by the prosthesis, and to find ways of optimizing the system, the scientists carried out a large-scale experiment on rodents.  By combining their skills in ophthalmology and the physiology of vision, they compared the response of the visual system of rodents to both natural visual stimuli and those generated by the prosthesis.

Their work showed that the prosthesis activated the visual cortex of the rodent in the correct position and at ranges comparable to those obtained under natural conditions.  However, the extent of the activation was much too great, and its shape was much too elongated.  This deformation was due to two separate phenomena observed at the level of the electrode matrix. Firstly, the scientists observed excessive electrical diffusion: the thin layer of liquid situated between the electrode and the retina passively diffused the electrical stimulus to neighboring nerve cells. And secondly, they detected the unwanted activation of retinal fibers situated close to the cells targeted for stimulation.

Armed with these findings, the scientists were able to improve the properties of the interface between the prosthesis and retina, with the help of specialists in interface physics.  Together, they were able to generate less diffuse currents and significantly improve artificial activation, and hence the performance of the prosthesis.

This lengthy study, because of the range of parameters covered (to study the different positions, types and intensities of signals) and the surgical problems encountered (in inserting the implant and recording the images generated in the animal’s brain) has nevertheless opened the way towards making promising improvements to retinal prostheses for humans.

This work was carried out by scientists from the Institut de Neurosciences de la Timone (CNRS/AMU) and AP-HM, in collaboration with CEA-Leti and the Institut de la Vision (CNRS/Inserm/UPMC).

Artificial retinas


© F. Chavane & S. Roux.

Activation (colored circles at the level of the visual cortex) of the visual system by prosthetic stimulation (in the middle, in red, the insert shows an image of an implanted prosthesis) is greater and more elongated than the activation achieved under natural stimulation (on the left, in yellow). Using a protocol to adapt stimulation (on the right, in green), the size and shape of the activation can be controlled and are more similar to natural visual activation (yellow).


Here’s a link to and a citation for the paper,

Probing the functional impact of sub-retinal prosthesis by Sébastien Roux, Frédéric Matonti, Florent Dupont, Louis Hoffart, Sylvain Takerkart, Serge Picaud, Pascale Pham, and Frédéric Chavane. eLife 2016;5:e12687 DOI: http://dx.doi.org/10.7554/eLife.12687 Published August 23, 2016

This paper appears to be open access.

Carbon nanotubes: OCSiAl’s deal in Korea and their effect on the body after one year

I have two news items related only by their focus on carbon nanotubes. First, there’s a July 3, 2014 news item on Azonano featuring OCSiAl’s deal with a Korean company announced at NANO KOREA 2014,

At NANO KOREA 2014 OCSiAl announced an unprecedentedly large-scale deal with Korean company Applied Carbon Nano Technology [ACN] Co., Ltd. – one of the key industry players.

OCSiAl, the dominating graphene tubes manufacturer, that successfully presented its products and technology in Europe and USA, now to enter Asian nanotech markets. At NANO KOREA 2014 the company introduced TUBALL, the universal nanomodifier of materials featuring >75% of single wall carbon nanotubes, and announced signing of supply agreement with Applied Carbon Nano Technology Co., Ltd. (hereinafter referred to as ACN), a recognized future-oriented innovative company.

A July 3, 2014 OCSiAl news release, which originated the news item, describes the memorandum of understanding (MOU) in greater detail,

Under this MoU ACN would buy 100 kg of TUBALL. The upcoming deal is the first of OCSiAl’s Korean contracts to be performed in 2015 and it turns up the largest throughout SWCNT market, which annual turnover recently hardly reached 500 kg. The agreement is exceptionally significant as it opens fundamental opportunities for manufacturing of new nanomaterial-based product with the unique properties that were not even possible before.

“OCSiAl’s entry to Korean market required thorough preparation. We invested time and efforts to prove that our company, our technology and our products worth credibility, – says Viktor Kim, OCSiAl Vice President, – we urged major playmakers to take TUBALL for testing to verify the quality and effectiveness. We believe that ACN is more than an appropriate partner to start – they are experts at the market and they understand its future perspectives very clearly. We believe that mutually beneficial partnership with ACN will path the way for future contracts, since it will become indicative to other companies in Asia and all over the world”.

“It comes as no surprise that OCSiAl’s products here in Korea will be in a great demand soon. The country strives to become world’s leader in advanced technology, and we do realize the benefits of nanomaterial’s exploitation. TUBALL is a truly versatile additive which may be used across many market sectors, where adoption of new materials with top-class performance is essential”, – says Mr. Dae-Yeol Lee, CEO of ACN.

OCSiAl’s entering to Korean market will undoubtedly have a high-reaching impact on the industry. The recent merger with American Zyvex Technologies made OCSiAl the not only the world’s largest nanomaterial producer but a first-rate developer of modifiers of different materials based on carbon nanotubes. To its Korean partners OCSiAl offers TUBALL, the raw ‘as produced’ SWCNT material and masterbatches, which can be either custom-made or ready-to-use mixtures for different applications, including li-ion batteries, car tires, transparent conductive coatings and many others. “Since Korea is increasingly dynamic, our success here will build on continuous development of our product, – adds Viktor Kim, – And we are constantly working on new applications of graphene tubes to meet sophisticated demands of nanotech-savvy Korean consumers”.

OCSiAl’s Zyvex acquisition was mentioned in a June 23, 2014 posting here.

My second tidbit concerns a July 4, 2014 news item on Nanowerk about carbon nanotubes and their effect on the body (Note: A link has been removed),

Having perfected an isotope labeling method allowing extremely sensitive detection of carbon nanotubes in living organisms, CEA and CNRS researchers have looked at what happens to nanotubes after one year inside an animal. Studies in mice revealed that a very small percentage (0.75%) of the initial quantity of nanotubes inhaled crossed the pulmonary epithelial barrier and translocated to the liver, spleen, and bone marrow. Although these results cannot be extrapolated to humans, this work highlights the importance of developing ultrasensitive methods for assessing the behavior of nanoparticles in animals. It has been published in the journal ACS Nano (“Carbon Nanotube Translocation to Distant Organs after Pulmonary Exposure: Insights from in Situ 14C-Radiolabeling and Tissue Radioimaging”).

A July 1, 2014 CNRS [France Centre national de la recherche scientifique] press release, which originated the news item, describes both applications for carbon nanotubes and the experiment in greater detail,

Carbon nanotubes are highly specific nanoparticles with outstanding mechanical and electronic properties that make them suitable for use in a wide range of applications, from structural materials to certain electronic components. Their many present and future uses explain why research teams around the world are now focusing on their impact on human health and the environment.

Researchers from CEA and the CNRS joined forces to study the distribution over time of these nanoparticles in mice, following contamination by inhalation. They combined radiolabeling with radio imaging tools for optimum detection sensitivity. When making the carbon nanotubes, stable carbon (12C) atoms were replaced directly by radioactive carbon (14C) atoms in the very structure of the tubes. This method allows the use of carbon nanotubes similar to those produced in industry, but labeled with 14C. Radio imaging tools make it possible to detect up to twenty or so carbon nanotubes on an animal tissue sample.

A single dose of 20 µg [micrograms] of labeled nanotubes was administered at the start of the protocol, then monitored for one year. The carbon nanotubes were observed to translocate from the lungs to other organs, especially the liver, spleen, and bone marrow. The study demonstrates that these nanoparticles are capable of crossing the pulmonary epithelial barrier, or air-blood barrier. It was also observed that the quantity of carbon nanotubes in these organs rose steadily over time, thus demonstrating that these particles are not eliminated on this timescale. Further studies will have to determine whether this observation remains true beyond a year.

The CEA [French Alternative Energies and Atomic Energy Commission {Commissariat à l’énergie atomique et aux énergies alternatives}] and CNRS teams have developed highly specific skills that enable them to study the health and environmental impact of nanoparticles from various angles. Nanotoxicology and nanoecotoxicology research such as this is both a priority for society and a scientific challenge, involving experimental approaches and still emerging concepts.

This work is conducted as part of CEA’s interdisciplinary Toxicology and Nanosciences programs. These are management, coordination and support structures set up to promote multidisciplinary approaches for studying the potential impact on living organisms of various components of industrial interest, including heavy metals, radionuclides, and new products.

At the CNRS, these concerns are reflected in particular in major initiatives such as the International Consortium for the Environmental Implications of Nano Technology (i-CEINT), a CNRS-led international initiative focusing on the ecotoxicology of nanoparticles. CNRS teams also have a long tradition of close involvement in matters relating to standards and regulations. Examples of this include the ANR NanoNORMA program, led by the CNRS, or ongoing work within the French C’Nano network.

For those who would either prefer or like to check out  the French language version of the July 1, 2014 CNRS press release (La biodistribution des nanotubes de carbone dans l’organisme), it can be found here.

Here’s a link to and a citation for the paper,

Carbon Nanotube Translocation to Distant Organs after Pulmonary Exposure: Insights from in Situ 14C-Radiolabeling and Tissue Radioimaging by Bertrand Czarny, Dominique Georgin, Fannely Berthon, Gael Plastow, Mathieu Pinault, Gilles Patriarche, Aurélie Thuleau, Martine Mayne L’Hermite, Frédéric Taran, and Vincent Dive. ACS Nano, 2014, 8 (6), pp 5715–5724 DOI: 10.1021/nn500475u Publication Date (Web): May 22, 2014

Copyright © 2014 American Chemical Society

This paper is behind a paywall.

Nanosilver disinfectant spray: final report from the US Environmental Protection Agency

The Aug.5, 2012 news item on Nanowerk is an announcement of the final report from the US Environmental Protection Agency’s (EPA) National Center for Environmental Assessment on nanosilver  (nano Ag) disinfectant spray,

This report presents a case study of engineered nanoscale silver (nano-Ag), focusing on the specific example of nano-Ag as possibly used in disinfectant sprays.
This case study is organized around the comprehensive environmental assessment (CEA) framework, which structures available information pertaining to the product life cycle, environmental transport and fate, exposure-dose in receptors (i.e., humans, ecological populations, and the environment), and potential impacts in these receptors. The document does not draw conclusions about potential risks. Instead, it is intended to be used as part of a process to identify what is known and unknown about nano-Ag in a selected application. In turn, the external review draft of the document provided a starting point to identify and prioritize possible research directions to support future assessments of nanomaterials.

The Nanomaterial Case Study: Nanoscale Silver in Disinfectant Spray (Final Report) is approximately 423 pages and the comprehensive environmental assessment framework mentioned seems to be an analytical tool used to establish directions for future research. In a July 5, 2012 posting (Toxicology convo heats up: OECD releases report on inhalation toxicity testing and Nature Nanotechnology publishes severe critique of silver toxicity overanalysis) I made note of some comments on inhalation testing and reports about nanosilver toxicity issued by international institutions that seem à propos in this context. (I first wrote about this study in an Aug. 17, 2010 posting when the EPA had released a draft version for comments.)

Nanomaterials and toxicology (US Environmental Protection Agency and National Institute of Occupational Health and Safety)

It seems to be ‘toxicology and nanomaterials’ season right now. In addition to the ISO (International Standards Organization) technical report on nanomaterials and toxicology which was released in early June (mentioned in my June 4, 2012 posting), the US Environmental Protection Agency (EPA) and the US National Institute of Occupational Safety and Health (NIOSH) have released new reports.

Yesterday (July 2, 2012), the EPA posted a notice on the US Federal Register about a report, a commenting period, and a public information exchange meeting for “Nanomaterial Case Study: A Comparison of Multiwalled Carbon Nanotubes and Decabromodiphenyl Ether Flame-Retardant Coatings Applied to Upholstery Textiles.”

As I noted in an Aug. 27, 2010 posting, the EPA has adopted a very interesting approach to studying possible toxicological effects due to nanomaterials (and other materials),

Such case studies do not represent completed or even preliminary assessments; rather, they are intended as a starting point in a process to identify and prioritize possible research directions to support future assessments of nanomaterials.

Part of the rationale for focusing on a series of nanomaterial case studies is that such materials and applications can have highly varied and complex properties that make considering them in the abstract or in generalities quite difficult. Different materials and different applications of a given material could raise unique questions or issues as well as some issues that are common to various applications of a given nanomaterial or even to different nanomaterials. After several individual case studies have been examined, refining a strategy for nanomaterials research to support long-term assessment efforts should be possible. (p. 19 PDF, p. 1-1 in print version of a  US EPA silver nanomaterials draft report)

The July 3, 2012 news item on Nanowerk offers more detail about this latest case study (Note: I have removed a link),

EPA announces the release of the draft report, Nanomaterial Case Study: A Comparison of Multiwalled Carbon Nanotube and Decabromodiphenyl Ether Flame-Retardant Coatings Applied to Upholstery Textiles (External Review Draft), for public viewing and comment. This was announced in a July 2, 2012 Federal Register Notice  along with information about the upcoming public Information Exchange Meeting scheduled for October 29, 2012. The purpose of this meeting is to receive comments and questions on the draft document, as well as provide information on the draft document and a workshop process that it will be used in, which is being conducted independently by RTI International, a contractor for EPA. The deadline for comments on the draft document is August 31, 2012. [emphases mine]

The notice on the EPA website offers details and extensive links to satisfy your information needs on this matter,

The draft document is intended to be used as part of a process to identify what is known and, more importantly, what is not yet known that could be of value in assessing the broad implications of specific nanomaterials. Like previous case studies (see History/ Chronology below [on the EPA website]), this draft case study on multiwalled carbon nanotubes (MWCNTs) is based on the comprehensive environmental assessment (CEA) approach, which consists of both a framework and a process. Unlike previous case studies this case study incorporates information about a traditional (i.e., “non-nano-enabled”) product, against which the MWCNT flame-retardant coating applied to upholstery textiles (i.e., the “nano-enabled” product) can be compared. The comparative element serves dual-purposes: 1) to provide a more robust database that facilitates identification of data gaps related to the nano-enabled product and 2) to provide a context for identifying key factors and data gaps for future efforts to evaluate risk-related trade-offs between a nano-enabled and non-nano-enabled product.

This draft case study does not represent a completed or even a preliminary assessment of MWCNTs; rather, it uses the CEA framework to structure information from available literature and other resources (e.g., government reports) on the product life cycle, fate and transport processes in various environmental media, exposure-dose characterization, and impacts in human, ecological, and environmental receptors. Importantly, information on other direct and indirect ramifications of both primary and secondary substances or stressors associated with the nanomaterial is also included when available. The draft case study provides a basis for the next step of the CEA process, whereby collective judgment is used to identify and prioritize research gaps to support future assessment efforts that inform near-term risk management goals.

Meanwhile, NIOSH has released a safety guide (from the June 29, 2012 news item on Nanowerk),

The National Institute for Occupational Safety and Health (NIOSH) has published “General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories” (pdf).

With the publication of this document, NIOSH hopes to raise awareness of the occupational safety and health practices that should be followed during the synthesis, characterization, and experimentation with engineered nanomaterials in a laboratory setting. The document contains recommendations on engineering controls and safe practices for handling engineered nanomaterials in laboratories and some pilot scale operations. This guidance was designed to be used in tandem with well-established practices and the laboratory’s chemical hygiene plan. As our knowledge of nanotechnology increases, so too will our efforts to provide additional guidance materials for working safely with engineered nanomaterials.

Here is more information  from the executive summary of the General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories,

Risk Management

Risk management is an integral part of occupational health and safety. Potential expo­sures to nanomaterials can be controlled in research laboratories through a flexible and adaptive risk management program. An effective program provides the framework to anticipate the emergence of this technology into laboratory settings, recognize the po­tential hazards, evaluate the exposure to the nanomaterial, develop controls to prevent or minimize exposure, and confirm the effectiveness of those controls.

Hazard Identification

Experimental animal studies indicate that potentially adverse health effects may result from exposure to nanomaterials. Experimental studies in rodents and cell cultures have shown that the toxicity of ultrafine particles or nanoparticles is greater than the toxicity of the same mass of larger particles of similar chemical composition.

Research demonstrates that inhalation is a significant route of exposure for nanoma­terials. Evidence from animal studies indicates that inhaled nanoparticles may deposit deep in lung tissue, possibly interfering with lung function. It is also theorized that nanoparticles may enter the bloodstream through the lungs and transfer to other or­gans. Dermal exposure and subsequent penetration of nanomaterials may cause local or systemic effects. Ingestion is a third potential route of exposure. Little is known about the possible adverse effects of ingestion of nanomaterials, although some evidence sug­gests that nanosized particles can be transferred across the intestinal wall.

Exposure Assessment

Exposure assessment is a key element of an effective risk management program. The ex­posure assessment should identify tasks that contribute to nanomaterial exposure and the workers conducting those tasks. An inventory of tasks should be developed that in­cludes information on the duration and frequency of tasks that may result in exposure, along with the quantity of the material being handled, dustiness of the nanomaterial, and its physical form. A thorough understanding of the exposure potential will guide exposure assessment measurements, which will help determine the type of controls re­quired for exposure mitigation.

Exposure Control

Exposure control is the use of a set of tools or strategies for decreasing or eliminating worker exposure to a particular agent. Exposure control consists of a standardized hi­erarchy to include (in priority order): elimination, substitution, isolation, engineering controls, administrative controls, or if no other option is available, personal protective equipment (PPE).

Substitution or elimination is not often feasible for workers performing research with nanomaterials; however, it may be possible to change some aspects of the physical form of the nanomaterial or the process in a way that reduces nanomaterial release.

Isolation includes the physical separation and containment of a process or piece of equipment, either by placing it in an area separate from the worker or by putting it within an enclosure that contains any nanomaterials that might be released.

Engineering controls include any physical change to the process that reduces emissions or exposure to the material being contained or controlled. Ventilation is a form of engi­neering control that can be used to reduce occupational exposures to airborne particu­lates. General exhaust ventilation (GEV), also known as dilution ventilation, permits the release of the contaminant into the workplace air and then dilutes the concentration to an acceptable level. GEV alone is not an appropriate control for engineered nano­materials or any other uncharacterized new chemical entity. Local exhaust ventilation (LEV), such as the standard laboratory chemical hood (formerly known as a laboratory fume hood), captures emissions at the source and thereby removes contaminants from the immediate occupational environment. Using selected forms of LEV properly is ap­propriate for control of engineered nanomaterials.

Administrative controls can limit workers’ exposures through techniques such as us­ing job-rotation schedules that reduce the time an individual is exposed to a substance. Administrative controls may consist of standard operating procedures, general or spe­cialized housekeeping procedures, spill prevention and control, and proper labeling and storage of nanomaterials. Employee training on the appropriate use and handling of nanomaterials is also an important administrative function.

PPE creates a barrier between the worker and nanomaterials in order to reduce expo­sures. PPE may include laboratory coats, impervious clothing, closed-toe shoes, long pants, safety glasses, face shields, impervious gloves, and respirators.

Other Considerations

Control verification or confirmation is essential to ensure that the implemented tools or strategies are performing as specified. Control verification can be performed with traditional industrial hygiene sampling methods, including area sampling, personal sampling, and real-time measurements. Control verification may also be achieved by monitoring the performance parameters of the control device to ensure that design and performance criteria are met.

Other important considerations for effective risk management of nanomaterial expo­sure include fire and explosion control. Some studies indicate that nanomaterials may be more prone to explosion and combustion than an equivalent mass concentration of larger particles.

Occupational health surveillance is used to identify possible injuries and illnesses and is recommended as a key element in an effective risk management program. Basic medical screening is prudent and should be conducted under the oversight of a qualified health-care professional. (pp. 9 – 11 PDF or pp. vii – ix in print)

The guidance as per the executive summary seems to rely heavily on what I imagine are industrial hygiene practices that should be followed whether or not laboratories are researching nanomaterials.

Carbon and neural implants

I’ve been meaning to do more about brains and implantable devices for a while so this Mar. 2, 2012 news item on Nanowerk comes at a timely moment,

The blind see, the lame walk, and the deaf hear: in the future, neural implants could replace destroyed sensory cells in the eye or ear – a dream come true for humanity. One of the greatest challenges yet to be addressed is designing the interface between medical technology and human tissue. In order to overcome the limitations of existing models, scientists from Forschungszentrum Jülich and eleven other institutions involved in the NeuroCare project, which kicked off on 1 March 2012, will develop novel biointerfaces made of carbon.

After reading some of Dr. Gregor Wolbring’s materials (last mentioned in my Aug. 30, 2011 posting on ‘ableism’) I’m not so sure about this business of making the ‘blind see’, etc. For example, there’s been  a lot of discussion in the deaf community about cochlear implants and whether or not there should be an automatic assumption that to be ‘normal’, one must hear. Wolbring’s latest writing on these topics is here in a Feb. 23, 2012 posting on the Nordic Network on Disability Research blog. Excerpted from the posting,

I coined a couple of years ago the term Ability Studies (Wolbring, 2008) which I defined, among others, to investigate: (a) the social, cultural, legal, political, ethical and other considerations by which any given ability may be judged, and which may lead to favouring one ability over another; (b) the impact and consequence of favouring certain abilities and rejecting others; (c) the consequences of ableism in its different forms, and its relationship with and impact on other isms [racism, ageism, sexism, etc.].

I think Wolbring asks some very provocative questions in light of the enthusiasm so often expressed in descriptions of greater therapeutic interventions. From the news item,

For several years, biomedical researchers have been working on implants to compensate for damage to the nervous system caused by an accident or illness. They focus on tools that correct problems with basic cognitive abilities, such as a loss or impairment of eyesight or the ability to hear. In addition, they may also be used to treat traumatic injuries to the spine, drug-resistant epilepsies, psychiatric disorders, and chronic neurodegenerative diseases.

However, the technology is still in its infancy. What makes it so difficult to implement is primarily connecting living tissue and electric circuits, with flexible cell structures containing water on one side and rigid solid electrodes on the other side. NeuroCare therefore uses materials based on carbon as they are better suited to medical purposes than the metals or silicon conventionally used.

In order to optimize the contact to biological tissue, the researchers are planning to experiment with flexible materials and test different surface structures on the nanometre scale. Within the next three years, the project coordinated by the French Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA) will produce prototypes of retinal, cortical and cochlear implants, which will then be refined until they can be brought to the market in the following ten years.

The NeuroCare (Neuronal NanoCarbon Interfacing Structures) project is described in a more technical fashion on the Cordis website where contact information for various partners in the project is also offered.